CompletedPhase 3NCT01160263

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Lucette Lacomblez, MD
Pitié-Salpêtrière Hospital
Intervention
SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM(drug)
Enrollment
16 enrolled
Eligibility
39-66 years · All sexes
Timeline
2012 – 2014

Study locations (2)

Collaborators

Association Française contre les Myopathies (AFM), Paris · ARS (Association pour la Recherche sur la Sclérose Latérale Amyotrophique) · Agence Générale des Equipements et Produits de Santé

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01160263 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis →

← Back to all trials